Combivent and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Combivent (albuterol sulfate; ipratropium bromide), especially for people who are male, 60+ old, also take Albuterol, and have Emphysema.

The phase IV clinical study analyzes which people have Hyperventilation when taking Combivent. It is created by eHealthMe based on reports of 35,104 people who have side effects when taking Combivent from the FDA, and is updated regularly.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,340 Combivent users. Check the latest studies of Combivent.

What is Hyperventilation?

Hyperventilation is found to be associated with 872 drugs and 1,429 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Oct, 02, 2025

35,104 people reported to have side effects when taking Combivent.
Among them, 24 people (0.07%) have Hyperventilation.

Among these 24 people:

What is the gender of people who have Hyperventilation when taking Combivent? *

female: 47.83 %
male: 52.17 %

What is the age of people who have Hyperventilation when taking Combivent? *

What are other drugs people take besides Combivent? *

What are other side effects people have besides Hyperventilation? *

Chest Pain: 10 people, 41.67%
Stress And Anxiety: 8 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 25.00%
Cough: 6 people, 25.00%
Fatigue (feeling of tiredness): 5 people, 20.83%
Agitation (state of anxiety or nervous excitement): 5 people, 20.83%
Mood Swings (an extreme or rapid change in mood): 4 people, 16.67%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 4 people, 16.67%
Rashes (redness): 3 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%

What are the existing conditions these people have? *

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 20.83%
Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 3 people, 12.50%
Chest Pain: 3 people, 12.50%
Pain: 2 people, 8.33%
Diabetes: 2 people, 8.33%
Urination - Painful: 1 person, 4.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.17%
Blood Pressure Abnormal: 1 person, 4.17%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 4.17%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Combivent:

Combivent (35,340 reports)

Hyperventilation treatments and more:

Hyperventilation (8,308 reports)

How severe was Hyperventilation and when was it recovered:

Hyperventilation in Combivent

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (872 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,429 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Combivent) and Combivent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.